Prognostic factor analysis for plaque psoriasis

Dermatology

Volumn 211, Issue 2, 2005, Pages 103-106

  Sakai, Rie ^a   Matsui, Shigeyuki ^a   Fukushima, Masanori ^a   Yasuda, Hideyo ^b   Miyauchi, Harumitsu ^b   Miyachi, Yoshiki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Prognostic factor; Prognostic index; Psoriasis, clinical research

Indexed keywords

CYCLOSPORIN A; ETRETINATE; PSORALEN; TACALCITOL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FACTORIAL ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PSORIASIS VULGARIS; SEX DIFFERENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BODY MASS INDEX; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROBABILITY; PROGNOSIS; PSORIASIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SICKNESS IMPACT PROFILE; TIME FACTORS;

EID: 23844475523     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086437     Document Type: Article

References (15)

1. Christophers E, Sterry W: Psoriasis; in Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg TM, Austen KF (eds): Dermatology in General Medicine. New York, McGraw-Hill, 1993, pp 489-514.
2. Griffiths CE, Clark CM, Chalmers RJ, et al: A systematic review of treatments for severe psoriasis. Health Technol Assess 2000;4:1-125.
3. Granstein RD: New treatments for psoriasis. N Engl J Med 2001;345:284-287.
4. Monk BE, Neill SM: Alcohol consumption and psoriasis. Dermatologica 1986;173:57-60.
5. Gupta MA, Schork NJ, Gupta AK, Ellis CN: Alcohol intake and treatment responsiveness of psoriasis: A prospective study. J Am Acad Dermatol 1993;28:730-732.
6. Gupta MA, Gupta AK, Watteel GN: Cigarette smoking in men may be a risk factor for increased severity of psoriasis of the extremities. Br J Dermatol 1996;135:859-860.
7. Zhang X, Wang H, Te-Shao H, et al: Frequent use of tobacco and alcohol in Chinese psoriasis patients. Int J Dermatol 2002;41:659-662.
8. Faust HB, Gonin R, Chuang TY, et al: Reliability testing of the dermatology index of disease severity (DIDS). Arch Dermatol 1997;133:1443-1448.
9. Ashcroft DM, Wan Po AL, Williams HC, Griffiths CE: Clinical measures of disease severity and outcome in psoriasis: A critical appraisal of their quality. Br J Dermatol 1999;141:185-191.
10. Rocha-Pereira P, Santos-Silva A, Rebelo I, et al: Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 2001;303:33-39.
11. World Health Organization: Obesity: Preventing and Managing the Global Epidemic Report of a WHO Consultation on Obesity. Geneva, World Health Organization, 1997.
12. Henseler T, Christophers E: Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985;13:450-456.
13. Cordain L, Lindeberg S, Hurtado M, et al: Acne vulgaris: A disease of western civilization. Arch Dermatol 2002;138:1584-1590.
14. A predictive model for aggressive non-Hodgkin's lymphoma: The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987-994.
15. Altman DG, Royston P: What do we mean by validating a prognostic model? Stat Med 2000;19:453-473.